Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease

被引：0
|
作者：
van Hoeve, K. [1 ]
Dreesen, E. [2 ]
Hoffman, I. [1 ]
Ferrante, M. [3 ]
Vermeire, S. [3 ]
机构：
[1] Univ Hosp Leuven, Dept Paediat Gastroenterol & Hepatol & Nutr, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P389
引用
收藏
页码：S362 / S363
页数：2
相关论文
共 50 条
  • [41] Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
    Martinez Ibeas, M. A.
    Bacelo Ruano, I.
    Rodriguez Manchon, S.
    Velasco Rodriguez-Belvis, M.
    Viada Bris, J. F.
    Dominguez Ortega, G.
    Munoz Codoceo, R. A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S573 - S573
  • [42] Long-term outcome of immunomodulators use in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S143 - S144
  • [43] Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, Eleni
    Gazouli, Maria
    Foteinogiannopoulou, Kalliopi
    Theodoraki, Eirini
    Legaki, Evangelia
    Romanos, Ioannis
    Mouzas, Ioannis
    Koutroubakis, Ioannis E.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (02) : 187 - 191
  • [44] Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
    Parra, Rogerio S.
    Feitosa, Marley R.
    Ribeiro, Leticia C. H.
    Castro, Lais A.
    Rocha, Jose J. R.
    Feres, Omar
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [45] Long-Term Safety and Efficacy of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease
    Mock, Joseph D.
    Tuskey, Anne G.
    Rubin, Amy
    Behm, Brian W.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S257 - S257
  • [46] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Konstantinos Papamichael
    Ravy K. Vajravelu
    Mark T. Osterman
    Adam S. Cheifetz
    [J]. Digestive Diseases and Sciences, 2018, 63 : 761 - 767
  • [47] Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease
    Papamichael, Konstantinos
    Vajravelu, Ravy K.
    Osterman, Mark T.
    Cheifetz, Adam S.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) : 761 - 767
  • [48] Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy
    van Hoeve, Karen
    Tabib, Nasim Sadat Seyed
    Dreesen, Erwin
    Tops, Sophie
    Hoffman, Ilse
    Gils, Ann
    Ferrante, Marc
    Vermeire, Severine
    [J]. JOURNAL OF PEDIATRICS, 2022, 240 : 150 - +
  • [49] Long-term clinical outcome after infliximab discontinuation in patients with inflammatory bowel disease
    Lee, Ji Min
    Kim, Yoon Jae
    Lee, Kang-Moon
    Yoon, Hyuk
    Lee, Bo-In
    Kim, Dae Bum
    Kang, Donghoon
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10-11) : 1280 - 1285
  • [50] Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases
    Andres J. Yarur
    Alexandra Bruss
    Snehal Naik
    Poonam Beniwal-Patel
    Caroline Fox
    Anjali Jain
    Brandon Berens
    Amir Patel
    Ryan Ungaro
    Bayda Bahur
    Marla Dubinsky
    Daniel J. Stein
    [J]. Digestive Diseases and Sciences, 2019, 64 : 3674 - 3675
12345